Dual-pathway research blend
12 mg / 6 mg
$119.99
A research blend pairing a GHRH analog with a selective growth-hormone secretagogue for pathway studies.
For laboratory research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease.
Research overview
This blend combines tesamorelin, a GHRH analog, with ipamorelin, a selective growth-hormone secretagogue. The components act through distinct signaling routes; most published evidence evaluates them separately rather than as this specific blend.
Areas of investigation
Blend-specific evidence is limited; component-level research should not be treated as evidence for the finished blend.
Scholarly references
